On Oct. 1, Dr. L-J Pilaz gave a presentation about using CRISPR to edit mouse embryos to figure out more information about neurodegenerative disorders. “So, I’m presenting techniques that allow you to ...

- Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET ...

New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

Hepatitis B virus (HBV) infection is a significant global health issue, affecting over 200 million people worldwide. Chronic HBV infection can lead to severe liver diseases such as cirrhosis and ...

Here is a list of Nobel Prize in Chemistry winners over the past 10 years: 2023: Moungi Bawendi (United States-France-Tunisia), Louis Brus (United States) and Russian-born Alexei Ekimov for developing ...

As of October 2024, there are more than thirty FDA-approved gene therapies, spanning a diverse array of diseases such as ...

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...

This year's Nobel Prize in physiology or medicine was awarded to United States scientists Victor Ambros and Gary Ruvkun "for ...

Here are some of the most groundbreaking developments in science this week, ranging from a novel approach to rejuvenating ...

The treatment, involving the use of donor cells, has shown positive results in patients six months after receiving treatment.

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Editas Medicine (EDIT – Research Report) on October 4. The company’s ...